Prevalence of IGF1 deficiency in prepubertal children with isolated short stature

European Journal of Endocrinology

Volumn 161, Issue 1, 2009, Pages 43-50

  Edouard, T ^a,c   Grunenwald S ^b   Gennero, I ^c   Salles, J P ^a,c   Trauber, M ^a,c  

^a HÔPITAL DES ENFANTS   (France)

^b SERVICE DE PNEUMOLOGIE   (France)

^c CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; HUMAN GROWTH HORMONE;

ADOLESCENT; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; BODY MASS; BONE AGE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE DEFICIENCY; HUMAN; HUMAN CELL; INSULIN LIKE GROWTH FACTOR 1 DEFICIENCY; MALE; PATHOPHYSIOLOGY; PREPUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SCHOOL CHILD; SCREENING; SHORT STATURE; SMALL FOR DATE INFANT; GROWTH DISORDER; MASS SCREENING; METABOLISM; NUTRITIONAL DISORDER; PREVALENCE;

BODY HEIGHT; BODY MASS INDEX; CHILD; CHILD NUTRITION DISORDERS; CHILD, PRESCHOOL; FEMALE; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MASS SCREENING; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 67650742900     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0964     Document Type: Article

References (43)

1. Maghnie M, Ambrosini L, Cappa M, Pozzobon G, Ghizzoni L, Ubertini MG, di Iorgi N, Tinelli C, Pilia S, Chiumello G, Lorini R & Loche S. Adult height in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficiencies. Journal of Clinical Endocrinology and Metabolism 2006 91 2900-2905.
2. Soriano-Guillen L, Coste J, Ecosse E, Leger J, Tauber M, Cabrol S, Nicolino M, Brauner R, Chaussain JL & Carel JC. Adult height and pubertal growth in Turner syndrome after treatment with recombinant growth hormone. Journal of Clinical Endocrinology and Metabolism 2005 90 5197-5204.
3. Van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M & Hokken-Koelega A. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial. Journal of Clinical Endocrinology and Metabolism 2003 88 3584-3590.
4. Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, Roberts K, Gill A, Chaussain JL, Frisch H, Yturriaga R & Attanasio AF. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect. Journal of Pediatrics 2005 146 45-53.
5. Wit JM, Kamp GA & Rikken B. Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature. Pediatric Research 1996 39 295-302.
6. Ranke MB. Defining insulin-like growth factor-I deficiency. Hormone Research 2006 65 9-14.
7. Laron Z. Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003. Journal of Clinical Endocrinology and Metabolism 2004 89 1031-1044.
8. Chernausek SD, Backeljauw PF, Frane J, Kuntze J & Underwood LE. Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-1 deficiency due to growth hormone insensitivity. Journal of Clinical Endocrinology and Metabolism 2007 92 902-910.
9. Usher R & McLean F. Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. Journal of Pediatrics 1969 74 901-910.
10. Sempe MPG & Roy-Pernot MP. Auxologie, Méthodes et Séquences. Paris: Laboratoire Théraplix, 1979.
11. Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C & Charraud A. Body mass index variations: centiles from birth to 87 years. European Journal of Clinical Nutrition 1991 45 13-21.
12. Tanner J. Growth and Adolescence. Oxford: Blackwell, 1969.
13. Greulich W. Radiographic Atlas of Skeletal Development of the Hand and Wrist. Stanford: University Press, 1959.
14. Blum WF, Cotterill AM, Postel-Vinay MC, Ranke MB, Savage MO & Wilton P. Improvement of diagnostic criteria in growth hormone insensitivity syndrome: solutions and pitfalls. Pharmacia study group on insulin-like growth factor I treatment in growth hormone insensitivity syndromes. Acta Paediatrica 1994 399 117-124.
15. Attie KM, Julius JR, Stoppani C & Rundle AC. National Cooperative Growth Study substudy VI: the clinical utility of growth-hormone-binding protein, insulin-like growth factor I, and insulin-like growth factor-binding protein 3 measurements. Journal of Pediatrics 1997 131 S56-S60.
16. Clayton PE, Ayoola O & Whatmore AJ. Patient selection for IGF-1 therapy. Hormone Research 2006 65 28-34.
17. Wit JM, Finken MJ, Rijken M & de Zegher F. Preterm growth restraint: a paradigm that unifies intrauterine growth retardation and preterm extrauterine growth retardation and has implications for the small-for-gestational-age indication in growth hormone therapy. Pediatrics 2006 117 793-795.
18. Grimberg A, Kutikov JK & Cucchiara AJ. Sex differences in patients referred for evaluation of poor growth. Journal of Pediatrics 2005 146 212-216.
19. Green AA & MacFarlane JA. Method for the earlier recognition of abnormal stature. Archives of Disease in Childhood 1983 58 535-537.
20. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E, KiessW, Klammt J, Kratzsch J, Osgood D, Pfaffle R, Raile K, Seidel B, Smith RJ & Chernausek SD. IGF-1 receptor mutations resulting in intrauterine and postnatal growth retardation. New England Journal of Medicine 2003 349 2211-2222.
21. Woods KA, Camacho-Hubner C, Savage MO & Clark AJ. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. New England Journal of Medicine 1996 335 1363-1367.
22. Wudy SA, Hagemann S, Dempfle A, Ringler G, Blum WF, Berthold LD, Alzen G, Gortner L & Hebebrand J. Children with idiopathic short stature are poor eaters and have decreased body mass index. Pediatrics 2005 116 52-57.
23. Oerter KE, Sobel AM, Rose SR, Cristiano A, Malley JD, Cutler GB Jr & Baron J. Combining insulin-like growth factor-I and mean spontaneous nighttime growth hormone levels for the diagnosis of growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 1992 75 1413-1420.
24. Wit JM, Clayton PE, Rogol AD, Savage MO, Saenger PH & Cohen P. Idiopathic short stature: definition, epidemiology, and diagnostic evaluation. Growth Hormone and IGF Research 2008 18 89-110.
25. Gaethofs M, Verdonck A, Carels C & de Zegher F. Delayed dental age in boys with constitutionally delayed puberty. European Journal of Orthodontics 1999 21 711-715.
26. Reinehr T, de Sousa G & Wabitsch M. Relationships of IGF-1 and androgens to skeletal maturation in obese children and adolescents. Journal of Pediatric Endocrinology and Metabolism 2006 19 1133-1140.
27. Leger J, Mercat I, Alberti C, Chevenne D, Armoogum P, Tichet J & Czernichow P. The relationship between the GH/IGF-1 axis and serum markers of bone turnover metabolism in healthy children. European Journal of Endocrinology 2007 157 685-692.
28. Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard AM & Rosenfeld RG. Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study. Journal of Clinical Endocrinology and Metabolism 2007 92 2480-2486.
29. Attie KM, Carlsson LM, Rundle AC & Sherman BM. Evidence for partial growth hormone insensitivity among patients with idiopathic short stature. The National Cooperative Growth Study. Journal of Pediatrics 1995 127 244-250.
30. Buckway CK, Guevara-Aguirre J, Pratt KL, Burren CP & Rosenfeld RG. The IGF-1 generation test revisited: a marker of GH sensitivity. Journal of Clinical Endocrinology and Metabolism 2001 86 5176-5183.
31. Leger J, Noel M, Limal JM & Czernichow P. Growth factors and intrauterine growth retardation. II. Serum growth hormone, insulin-like growth factor (IGF) I, and IGF-binding protein 3 levels in children with intrauterine growth retardation compared with normal control subjects: prospective study from birth to two years of age. Study Group of IUGR. Pediatric Research 1996 40 101-107.
32. Deiber M, Chatelain P, Naville D, Putet G & Salle B. Functional hypersomatotropism in small for gestational age (SGA) newborn infants. Journal of Clinical Endocrinology and Metabolism 1989 68 232-234.
33. de Zegher F, Kimpen J, Raus J & Vanderschueren-Lodeweyckx M. Hypersomatotropism in the dysmature infant at term and preterm birth. Biology of the Neonate 1990 58 188-191.
34. Cianfarani S, Germani D, Rossi P, Rossi L, Germani A, Ossicini C, Zuppa A, Argiro G, Holly JM & Branca F. Intrauterine growth retardation: evidence for the activation of the insulin-like growth factor (IGF)-related growth-promoting machinery and the presence of a cation-independent IGF binding protein-3 proteolytic activity by two months of life. Pediatric Research 1998 44 374-380.
35. Grunt JA, Howard CP & Daughaday WH. Comparison of growth and somatomedin C responses following growth hormone treatment in children with small-for-date short stature, significant idiopathic short stature and hypopituitarism. Acta Endocrinologica 1984 106 168-174.
36. Ackland FM, Stanhope R, Eyre C, Hamill G, Jones J & Preece MA. Physiological growth hormone secretion in children with short stature and intra-uterine growth retardation. Hormone Research 1988 30 241-245.
37. de Waal WJ, Hokken-Koelega AC, Stijnen T, de Muinck Keizer-Schrama SM & Drop SL. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-1 and IGF-1I levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone. Clinical Endocrinology 1994 41 621-630.
38. Boguszewski M, Rosberg S & Albertsson-Wikland K. Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children. Journal of Clinical Endocrinology and Metabolism 1995 80 2599-2606.
39. Cianfarani S, Maiorana A, Geremia C, Scire G, Spadoni GL & Germani D. Blood glucose concentrations are reduced in children born small for gestational age (SGA), and thyroid-stimulating hormone levels are increased in SGAwith blunted postnatal catch-up growth. Journal of Clinical Endocrinology and Metabolism 2003 88 2699-2705.
40. Ranke MB. Sensitivity to IGF-1 in short children born small for gestational age. Journal of Endocrinological Investigation 2006 29 21-26.
41. Collett-Solberg PF & Misra M. The role of recombinant human insulin-like growth factor-I in treating children with short stature. Journal of Clinical Endocrinology and Metabolism 2008 93 10-18.
42. Amit T, Youdim MB & Hochberg Z. Clinical review 112: does serum growth hormone (GH) binding protein reflect human GH receptor function? Journal of Clinical Endocrinology and Metabolism 2000 85 927-932.
43. Pilecka I, Whatmore A, Hooft van Huijsduijnen R, Destenaves B & Clayton P. Growth hormone signalling: sprouting links between pathways, human genetics and therapeutic options. Trends in Endocrinology and Metabolism 2007 18 12-18.